The MHC class II molecule I-Ag7 exists in alternate conformations that are peptide dependent

被引:11
作者
Arneson, LS
Peterson, M
Sant, AJ
机构
[1] Univ Chicago, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Pathol, Comm Canc Biol, Chicago, IL 60637 USA
关键词
D O I
10.4049/jimmunol.165.4.2059
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Insulin-dependent diabetes mellitus is an autoimmune disease that is genetically linked to the HLA class II molecule DQ in humans and to MHC I-A(g7) in nonobese diabetic mice. The I-A(g7) beta-chain is unique and contains multiple polymorphisms, at least one of which is shared with DQ alleles linked to insulin-dependent diabetes mellitus. This polymorphism occurs at position 57 in the beta-chain, in which aspartic acid is mutated to a serine, a change that results in the loss of an interchain salt bridge between alpha Arg(76) and beta Asp(57) at the periphery of the peptide binding groove. Using mAbs we have identified alternative conformations of I-A(g7) class II molecules. By using an invariant chain construct with various peptides engineered into the class II-associated invariant chain peptide (CLIP) region we have found that formation of these conformations is dependent on the peptide occupying the binding groove. Blocking studies with these Abs indicate that these conformations are present at the cell surface and are capable of interactions with TCRs that result in T cell activation.
引用
收藏
页码:2059 / 2067
页数:9
相关论文
共 62 条
[1]   THE 1ST EXTERNAL DOMAIN OF THE NONOBESE DIABETIC MOUSE CLASS-II I-A BETA-CHAIN IS UNIQUE [J].
ACHAORBEA, H ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) :2435-2439
[2]   An altered invariant chain protein with an antigenic peptide in place of CLIP forms SDS-stable complexes with class II αβ dimers and facilitates highly efficient peptide loading [J].
Barton, GM ;
Rudensky, AY .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (08) :1159-1165
[3]  
BECK BN, 1984, J IMMUNOL, V133, P3176
[4]  
BRAUNSTEIN NS, 1990, J IMMUNOL, V145, P1635
[5]   IDENTIFICATION OF A CD4 BINDING-SITE ON THE BETA-2-DOMAIN OF HLA-DR MOLECULES [J].
CAMMAROTA, G ;
SCHEIRLE, A ;
TAKACS, B ;
DORAN, DM ;
KNORR, R ;
BANNWARTH, W ;
GUARDIOLA, J ;
SINIGAGLIA, F .
NATURE, 1992, 356 (6372) :799-801
[6]  
CarrascoMarin E, 1996, J IMMUNOL, V156, P450
[7]   TYPE-I DIABETES - A CHRONIC AUTOIMMUNE-DISEASE OF HUMAN, MOUSE, AND RAT [J].
CASTANO, L ;
EISENBARTH, GS .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :647-679
[8]   MAJOR HISTOCOMPATIBILITY COMPLEX CONFORMATIONAL EPITOPES ARE PEPTIDE SPECIFIC [J].
CATIPOVIC, B ;
DALPORTO, J ;
MAGE, M ;
JOHANSEN, TE ;
SCHNECK, JP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1611-1618
[9]  
Ceman S, 1995, Semin Immunol, V7, P373, DOI 10.1006/smim.1995.0042
[10]   The role of MHC class II molecules in susceptibility to type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire [J].
Chao, CC ;
Sytwu, HK ;
Chen, ELC ;
Toma, J ;
McDevitt, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :9299-9304